The Centers for Disease Control and Prevention (CDC) issued a health advisory on Thursday, alerting the public to an increasing number of reports nationwide concerning the presence of medetomidine, a veterinary sedative, in the illegal drug supply. Health officials are urging caution and increased vigilance due to the potentially dangerous effects of this substance when misused or unknowingly ingested.

The advisory details a concerning trend observed across various U.S. jurisdictions. Reports indicate that medetomidine is being mixed into illicit drugs, potentially including fentanyl and other substances. This contamination poses a significant risk to individuals who use drugs recreationally or unknowingly consume products containing the sedative.

Medetomidine is typically used by veterinarians to sedate animals, particularly for procedures requiring immobilization. In humans, it can cause significant physiological effects, including dangerously low blood pressure, slowed breathing, and decreased heart rate. These effects can be life-threatening, especially when combined with other depressants like opioids.

The CDC’s advisory emphasizes the difficulty in identifying medetomidine's presence in drugs, as it is often not apparent. This lack of visibility increases the risk of accidental overdose and adverse reactions. Public health officials are recommending that harm reduction organizations, healthcare providers, and law enforcement agencies remain alert to this emerging threat.

The CDC is working with state and local health departments to gather more information about the scope of this problem and to develop strategies to prevent further harm. Individuals who suspect they or someone they know has ingested a drug containing medetomidine should seek immediate medical attention. Naloxone, a medication used to reverse opioid overdoses, may not be effective in reversing the effects of medetomidine, highlighting the need for prompt and specialized medical care.